- Quipt Home Medical press release (NASDAQ:QIPT): FY GAAP EPS of -$0.16 misses by $0.05.
- Revenue of $245.9M (+16.2% Y/Y) misses by $7.39M.
- Adjusted EBITDA for Q4 2024 was $13.4 million (21.8% margin) compared to $14.7 million (24.6% margin) for Q4 2023, representing an 8.8% decrease.
- The Company maintains a conservative balance sheet with Net Debt to Adjusted EBITDA Leverage Ratio1 of 1.6x.
- Shares -7.49% AH.